Used as a key chiral intermediate in the synthesis of biologically active pharmaceuticals, particularly in the development of kinase inhibitors. Its structural features allow for selective interactions with enzyme targets, making it valuable in the production of drugs for cancer and inflammatory diseases. The compound's stereochemistry enhances binding affinity and specificity, improving drug efficacy and reducing off-target effects. Commonly employed in late-stage functionalization due to its stability and reactivity profile under various coupling conditions.